News on NASH

Video Courtesy of The NASH Education Program™



Click here for a brief synopsis. Video Courtesy of Pinnacle Clinical Research and AASLD TV


Organ crosstalk: Fatty liver can cause damage to other organ...

Date: 18 Aug 2017

Story by Science Daily.

According to the article, fatty liver increases the risk of chronic liver diseases (liver cirrhosis and liver cancer), as well as type 2 diabetes and cardiovascular diseases. How this happens is that the fatty liver increasingly produces glucose, unfavorable fats and proteins, such as the hepatokine fetuin-A, all of which it releases into the bloodstream and enters other organs, triggering adverse reactions.

Read More

Fibrosis, not NASH, predicts death, disease in fatty liver

Date: 15 Aug 2017

Story by Healio.

Nonalcoholic steatohepatitis did not increase the risk for liver-related morbidity, overall mortality or the time to development of severe liver disease in patients with nonalcoholic fatty liver disease, according to recently published data. However, fibrosis stage can be used as a significant marker.

Read More

NASH linked to early markers of hypertrophy

Date: 26 Jul 2017

Story by Healio.

Whether diastolic dysfunction similarly portends a risk of future [heart failure] among patients with NAFLD and/or NASH remains unknown, and we eagerly await well-designed, prospective studies to characterize this relationship.

Read More

AASLD releases NAFLD practice guides for screening, treatmen...

Date: 19 Jul 2017

Story by Healio.

In contrast to the incidence data, there is a significantly higher number of publications describing the prevalence of NAFLD in the general population.

Read More

Millions of people are living with a silent disease they've...

Date: 06 Jul 2017

Story by Business Insider.

NASH is set to surpass hepatitis as the biggest reason for liver transplants by 2020. That is seriously alarming!

Read More

NASH: KOL Insight [2017]

Date: 05 Jul 2017

By Report Buyer.

Key takeaway from experts on current study designs and endpoints, and the challenges facing novel therapies such as long-term safety, cost and diagnosis.

Read More

Fatty liver disease can be a silent killer

Date: 03 Jul 2017

Story by The New Paper, Singapore.

According to a report in Singapore's The New Paper (TNP), Non-alcoholic fatty liver disease - which can lead to liver cirrhosis or cancer - is on the rise in Singapore.

Read More

AASLD Foundation announces $3.34 Million in liver disease re...

Date: 30 Jun 2017

Story by AASLD.

“Liver disease continues to be a critical healthcare issue in the United States and internationally. Despite recent strides and successes in the treatment of many liver diseases, AASLD Foundation understands there is still much work to be done and more funding must be made available to those interested in hepatology.” - Bruce R. Bacon, MD, FAASLD, AASLD Foundation Chair.

Read More

Looking for clues for dangerous fatty liver disease

Date: 26 Jun 2017

Story by Medical Xpress

"When you combine the fact that the natural history of the disease is unclear; it's difficulty to diagnose, treat and stage it; and there's no FDA-approved medicine, it becomes a huge issue." - Dr. Jaideep Behari, associate professor of medicine at the University of Pittsburgh and director of Fatty Liver Clinic.

Read More

First-degree relatives of patients with NAFLD-cirrhosis at r...

Date: 19 Jun 2017

Story by Healio.

"According to researchers, first-degree relatives of patients with nonalcoholic fatty liver disease and cirrhosis have a 12-times higher risk for developing advanced fibrosis compared with first-degree relatives without NAFLD."

Read More

1 ... 4 5 6 7